Citation Impact
Citing Papers
V Diretrizes Brasileiras de Hipertensão Arterial
2007 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)
2020
Renal function and cardiovascular risk markers in a remote Australian Aboriginal community
2003
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
The metabolic syndrome
2010 Standout
New insight in the pathobiology of hepatitis B virus infection
2012
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability
2015
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
2014
Hepatitis B virus infection
2009 Standout
Hepatitis B cure: From discovery to regulatory approval
2017
The role of quantitative hepatitis B surface antigen revisited
2016
Current incidence, treatment patterns and outcome of end‐stage renal disease among indigenous groups in Australia and New Zealand
2003
Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients
2016
A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women
2012
Association of albuminuria and the metabolic syndrome
2003
Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants
2012
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
The metabolic syndrome
2005 Standout
Overview of hepatitis B viral replication and genetic variability
2016
Portal hypertensive bleeding in cirrhosis
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Association between microalbuminuria and the metabolic syndrome: NHANES III
2003
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Chronic kidney disease: global dimension and perspectives
2013 Standout
Oxidative Stress in Cancer
2020 Standout
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
2015
Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
2011
Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype
2012
树鼩——作为一种新颖的非人灵长类实验疾病动物模型
2017 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study
2014
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Ferroportin disease: pathogenesis, diagnosis and treatment
2017
Review article: chronic hepatitis B – anti‐viral or immunomodulatory therapy?
2010
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels
2012
High rates of albuminuria but not of low eGFR in Urban Indigenous Australians: the DRUID Study
2011
Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): A model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans
2012
Performance Evaluation of New Automated Hepatitis B Viral Markers in the Clinical Laboratory
2012
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
2015
Metabolic syndrome: Definition, pathophysiology, and mechanisms
2005
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B
2011
Genome‐free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy
2014
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Risk stratification for hepatitis B virus related hepatocellular carcinoma
2012
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE‐C II study
2016
Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
2015
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
2016
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
2017
Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection
2016
Increases of Cardiac Troponin in Conditions other than Acute Coronary Syndrome and Heart Failure
2009
Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study
2016
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression
2016
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Perspectives on HCV: Current Therapeutic Regimens and Drug–Drug Interactions
2017
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of David Iser being referenced
Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome
2000
Prospective study of cardiac troponin I release in patients with upper gastrointestinal bleeding
2007
Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection
2017
Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression
2010
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
2015
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
2010
The dynamics of hepcidin‐ferroportin internalization and consequences of a novel ferroportin disease mutation
2017
Short Duration Response-Guided Treatment is Effective for Most Individuals with Recent Hepatitis C Infection: The ATAHC II and DARE-C I Studies
2015
Fatty liver disease--a practical guide for GPs.
2013
Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors
2006
Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)–Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy
2014
Liver stiffness plus platelet count can be used to exclude high‐risk oesophageal varices
2015